Literature DB >> 26739184

Men With Severe Lower Urinary Tract Symptoms Are at Increased Risk of Depression.

Won Sik Jeong1, Hong Yong Choi1, Ji Won Nam2, Shin Ah Kim3, Bo Youl Choi2, Hong Sang Moon1, Kyu Shik Kim1.   

Abstract

PURPOSE: Lower urinary tract symptoms (LUTS) comprise a set of common, bothersome symptoms in middle-aged and elderly men. Recent research suggests that depressive symptoms may influence the symptoms of benign prostatic hyperplasia (BPH). We performed a community-based cross-sectional study to evaluate the correlation between LUTS and depression.
METHODS: The survey was conducted in a rural community during four periods in August 2009, 2010, 2011, and 2012. Two validated questionnaires were used to examine LUTS and depressive symptoms. These included the International Prostate Symptom Score/quality of life (IPSS/QoL) and the Korean version of the Center for Epidemiological Studies-Depression scale (CES-D-K). Patients were categorized in the depressive symptom group if their CES-D-K score was >16 points.
RESULTS: A total of 711 men were included in this study. Thirty-five participants (4.92%) were found to have depressive symptoms. There was a positive correlation between depressive symptoms and LUTS severity (P<0.001). As compared to the mild LUTS group, the odds ratio (OR) of depression was 2.868 (95% confidence interval [CI], 1.293-6.362; P for trend<0.001) in the moderate LUTS group, and 4.133 (95% CI, 1.510-11.313; P for trend<0.001) in the severe LUTS group. In a model considering multiple variables such as age, education level, smoking, and exercise, the OR in the moderate LUTS group was 2.534 (1.125-5.708, 95% CI, P for trend=0.005), while that in the severe LUTS group was 3.910 (95% CI, 5.708-11.154; P for trend=0.005). In addition, depression was related to voiding symptoms.
CONCLUSIONS: Men with severe LUTS are at higher risk of depression than those with less severe urinary symptoms. The severity of voiding symptoms worsens depression. More aggressive urological diagnosis and treatment is needed in patients with severe LUTS, due to the impact on depressive symptoms and QoL.

Entities:  

Keywords:  Depression; Lower Urinary Tract Symptoms; Prostatic Hyperplasia

Year:  2015        PMID: 26739184      PMCID: PMC4703937          DOI: 10.5213/inj.2015.19.4.286

Source DB:  PubMed          Journal:  Int Neurourol J        ISSN: 2093-4777            Impact factor:   2.835


INTRODUCTION

Depression is one of the most prevalent diseases worldwide, especially given its relationship with various chronic diseases. It is associated with an increased suicide rate, and is the cause of serious medical and social problems [1]. According to one Korean study, over the last 10 years, the lifetime prevalence of depression is 6.7% (men, 4.8%; women, 9.1%); this risk is increasing annually by 0.2% [2]. Depression has been associated with chronic diseases, including chronic obstructive pulmonary disease, inflammatory bowel disease, arthritis, diabetes, cancer, and myocardial infarction [3]. Lower urinary tract symptoms (LUTS) occur in >70% of men over 80 years of age [4]. Similarly, the prevalence of benign prostatic hyperplasia (BPH) is >80% in men 50–80 years old [5]. Therefore, a considerable number of elderly men with BPH also have LUTS. BPH is recognized as a primary cause of LUTS. One recent study clarified the risk factors for BPH and LUTS, including serum dihydrotestosterone, obesity, glucose homeostasis, diet, exercise, and inflammation [6-8]. Nocturia is one risk factor among LUTS for depression because it disturbs sleep at night [9,10]. There are both medical and surgical treatment options for BPH. Unfortunately, some BPH treatments may actually increase the risk of depression. For instance, 5-α reductase inhibitors may lead to erectile dysfunction [11]. Selective α1-adrenergic antagonists and transurethral resection of the prostate may result in retrograde ejaculation [12]. Several studies have recently reported that BPH and subsequent LUTS increase the incidence of depression and decrease the quality of life [13,14]. Based on these data, we performed a large, cross-sectional study to assess the relationship between BPH and depression.

MATERIAL AND METHODS

Patients and Study Design

This study was performed on a rural population (Yangpyeong, Gyeonggi-do) during August 2009, 2010, 2011, and 2012. The study included men over 40 years old. Multiple other parameters were analyzed, including education level, marital status, smoking, drinking, obesity (body mass index), regular exercise, and chronic disease (hypertension, diabetes). The correlation between depression and the degree of LUTS was investigated. In addition, during a live interview, participants completed a living habits-related questionnaire including demographic parameters. All of the participants were instructed to complete the International Prostate Symptom Score/quality of life (IPSS/QoL) and Korean version of the Center for Epidemiological Studies-Depression (CES-D-K) Questionnaires for analysis of LUTS and depression. The Institutional Review Board (IRB) of Hanyang University Guri Hospital reviewed and approved this study (2013-01-046).

Data Analysis

Patients were classified in the depressive symptom (DEP) group if their CES-D-K score exceeded 16 points.

The CES-D

The CES-D is a questionnaire that can be used to diagnose depression based on 20 items [15]. In this study, the questionnaire was translated into Korean. The DEPs were evaluated by each stage [16]. Measurements were performed by targeting test subjects with >16 points [17].

Statistical Analysis

The Cochran-Mantel-Haenszel test was used to analyze categorical variables. Independent t-tests and the general linear model were used to analyze continuous variables. In an analysis excluding age, P-value and P for trend correcting for age are presented. Logistic regression analysis was used to assess the correlation between LUTS and DEPs. The age correction model and multivariable model are presented. Variables that were correlated with LUTS were selected for calibration of the multivariable model. Statistical analyses were performed using two-way tests with α-error=0.05. Analyses were performed using the statistical package SAS 9.2 (SAS Institute Inc., Cary, NC, USA).

RESULTS

A total of 895 patients were initially included. Seven were excluded because they did not complete the questionnaire. In addition, 173 participants who did not complete the CES-D-K questionnaire and 4 who had missing informations in educational or marital status were excluded (Fig. 1). Ultimately, 711 men with an average age of 65.25±9.60 years were included in this study. Each participant was evaluated for age, education level, marital status, smoking, drinking, body mass index (kg/m2), regular exercise, and underlying diseases, including hypertension and diabetes. If participants scored >16 on the CES-D-K, they were classified in the DEP group (Table 1). A total of 35 (4.92%) were classified as having DEP. There was no significant age difference between the DEP and non-DEP groups (P=0.057). Demographic parameters and prevalence of obesity and chronic diseases (hypertension) were also not significantly different between the two groups.
Fig. 1.

Patient selection process. CES-D, Center for Epidemiological Studies-Depression scale.

Table 1.

Patient characteristics

CharacteristicTotal (n = 711)DEP (n = 35)Non-DEP (n = 676)P-value
Age (yr)65.25 ± 9.6068.23 ± 8.5265.09 ± 9.460.057
Educational status0.039
 High school or higher31710 (28.6)307 (45.4)
 Middle school1404 (11.4)136 (20.1)
 Elementary or below25421 (60.0)233 (34.5)
Marital status0.149
 Married66130 (85.7)631 (93.3)
 Single505 (14.3)45 (6.7)
Smoking status0.142
 Never1985 (14.3)193 (28.6)
 Ex-smoker35520 (57.1)335 (49.6)
 Current smoker15810 (28.6)148 (21.9)
Drinking status0.112
 Never1275 (14.3)122 (18.0)
 Ex-drinker10910 (28.6)99 (14.6)
 Current drinker47520 (57.1)455 (67.3)
Body mass index (kg/m2)0.274
 < 23.026517 (48.6)248 (36.7)
 23.0–24.917110 (28.6)161 (23.8)
 ≥ 252758 (22.9)267 (39.5)
Regular exercise0.041
 Yes2667 (20.0)259 (38.3)
 No44528 (80.0)417 (61.7)
Chronic diseases
 Hypertension0.456
  No42819 (54.3)409 (60.5)
  Yes28316 (45.7)267 (39.5)
 Diabetes0.040
  No60826 (74.3)582 (86.1)
  Yes1039 (25.7)94 (13.9)

Values are presented as mean±standard deviation or number (%).

DEP, depressive symptom.

A total of 468 patients experienced mild symptoms (IPSS score, 0–7), 183 had moderate symptoms (IPSS score, 8–19), and 60 had severe symptoms (IPSS score, 20–35). Depending on the age, there were significant correlations (P<0.001) between LUTS and relevance of demographic parameter, obesity, exercise, chronic disease (hypertension, diabetes) was not represented statistically (Table 2).
Table 2.

Selected characteristics according to lower urinary tract symptom severity

CharacteristicLUTS severity
P-valueP for trend
Mild (0–7)Moderate (8–19)Severe (20–35)
(n = 468)(n = 183)(n = 60)
Age (yr)63.01 ± 9.3069.1 ± 8.6870.97 ± 8.54< 0.001< 0.001
Educational status0.0440.002
 High school or higher237 (50.6)65 (35.5)15 (25.0)
 Middle school96 (20.5)32 (17.5)12 (20.0)
 Elementary or below135 (28.8)86 (47.0)33 (55.0)
Marital status0.0870.045
 Married (n = 661)442 (94.4)168 (91.8)51 (85.0)
 Single (n = 50)26 (5.6)15 (8.2)9 (15.0)
Smoking status0.0240.807
 Never (n = 198)142 (30.3)36 (19.7)20 (33.3)
 Ex-smoker (n = 355)218 (46.6)103 (56.3)34 (56.7)
 Current smoker (n = 158)108 (23.1)44 (24.0)6 (10.0)
Drinking status0.4740.272
 Never (n = 127)89 (19.0)30 (16.4)8 (13.3)
 Ex-drinker (n = 109)64 (13.7)32 (17.5)13 (21.7)
 Current drinker (n = 475)315 (67.3)121 (66.1)39 (65.0)
Body mass index (kg/m2)0.2630.569
 < 23.0 (n = 265)161 (34.4)73 (39.9)31 (51.7)
 23.0–24.9 (n = 171)119 (25.4)44 (24.0)8 (13.3)
 ≥ 25 (n = 275)188 (40.2)66 (36.1)21 (35.0)
Regular exercise0.0760.029
 Yes (n = 266)196 (41.9)54 (29.5)16 (26.7)
 No (n = 445)272 (58.1)129 (70.5)44 (73.3)
Chronic diseases
 Hypertension0.9040.904
  No (n = 428)287 (61.3)105 (24.5)36 (60.0)
  Yes (n = 283)181 (38.7)78 (27.6)24 (40.0)
 Diabetes0.8960.691
  No (n = 608)397 (84.8)158 (26.0)53 (88.3)
  Yes (n = 103)71 (15.2)25 (24.3)7 (11.7)

Values are presented as mean±standard deviation or number (%). All results are adjusted for age except age variable. P-values were calculated using the general linear model for continuous variables and Cochran-Mantel-Haenszel test for categorical variables.

There was a significant positive correlation between the prevalence of DEP and LUTS severity. In a group with mild LUTS, the prevalence of depression was only 2.8%. With moderate LUTS, the prevalence was 8.2%, and in the severe LUTS group, it was 11.7% (P for trend<0.001) (Fig. 2). The odds ratio (OR) of depression in the moderate LUTS group was 2.868 (95% CI, 1.293–6.362; P for trend<0.001). In the severe LUTS group, the OR was 4.133 (95% CI, 1.510–11.313; P for trend<0.001). The correlation of each IPSS component with depression was also calculated. The following were calculated for each component: frequency OR, 1.217 (95% CI, 1.018–1.454); urgency OR, 1.336 (95% CI, 1.140–1.567); weak stream OR, 1.237 (95% CI, 1.055–1.449); straining OR, 1.337 (95% CI, 1.141–1.567); and nocturia OR, 1.237 (95% CI, 1.056–1.400). Voiding symptoms had an OR of 2.694 (95% CI, 1.295–5.605), and storage symptoms, 2.441 (95% CI, 1.195–4.984). In the multivariable model, which also considered age, education level, smoking, and exercise, the moderate LUTS group had an OR of 2.5344 (95% CI, 1.125–5.708; P for trend=0.005) and the severe LUTS group OR was 3.910 (95% CI, 5.708–11.154; P for trend=0.005). Each IPSS component was also calculated: frequency OR, 1.201 (95% CI, 0.999–1.443); urgency OR, 1.308 (95% CI, 1.114–1.536); weak stream OR, 1.207 (95% CI, 1.026–1.420); straining OR, 1.309 (95% CI, 1.115–1.537); and nocturia OR, 1.208 (95% CI, 1.026–1.421). Voiding symptoms had an OR of 2.661 (95% CI, 1.267–5.588), and storage symptoms 2.042 (95% CI, 0.975–4.275) (Table 3).
Fig. 2.

Prevalence of depressive symptoms according to lower urinary tract symptoms (LUTS) severity. Results are adjusted for age (categorical variable). P-values and P for trend were calculated using Cochran-Manel-Haenszel test for categorical variables. P=0.002, P for trend<0.001. DEP, depressive symptom.

Table 3.

Correlation between depressive symptoms and LUTS severity

VariableAge-adjusted models
Multivariable models
OR(95% CI)OR(95% CI)
IPSS components, score/total score[a)]
 Feeling of incomplete emptying1.1951.022–1.3991.2131.034–1.424
 Frequency1.2171.018–1.4541.2010.999–1.443
 Intermittency1.1970.994–1.4431.1370.939–1.378
 Urgency1.3361.140–1.5671.3081.114–1.536
 Weak stream1.2371.055–1.4491.2071.026–1.420
 Straining1.3371.141–1.5671.3091.115–1.537
 Nocturia1.2371.056–1.4001.2081.026–1.421
 Quality of life score1.0490.817–1.3460.9970.771–1.288
LUTS severity[a)]
 Mild (0–7) (n = 468)1Reference1Reference
 Moderate (8–19) (n = 183)2.8681.293–6.3622.5341.125–5.708
 Severe (20–35) (n = 60)4.1331.510–11.3133.9105.708–11.154
 P for trend< 0.0010.005
 Continuous, 1 score/total score1.0741.033–1.1161.0681.026–1.112
Voiding symptoms[b)]
 Nonvoiding symptoms (n = 446)1Reference1Reference
 Voiding symptoms (n = 265)2.6941.295–5.6052.6611.267–5.588
 Continuous, 1 score1.111.051–1.1721.1061.047–1.169
Storage symptoms[c)]
 Nonstorage symptoms (n = 537)1Reference1Reference
 Storage symptoms (n = 174)2.4411.195–4.9842.0420.975–4.275
 Continuous, 1 score/total score1.0971.003–1.1991.0740.979–1.178

P-values for trend were determined using multivariable logistic regression analyses.

LUTS, lower urinary tract symptom; OR, odds ratio; CI, confidence interval; IPSS, International Prostate Symptom Score.

Multivariable model:

Adjusted for age (continuous), education status, marital status, smoking status, and regular exercise.

Adjusted for age (continuous), education status, marital status, and regular exercise; voiding symptoms: urgency, frequency, nocturia.

Adjusted for age (continuous), education status, marital status, body mass index, and regular exercise; storage symptoms: hesitancy, straining, feeling of incomplete emptying, intermittency, weak stream.

DISCUSSION

This cohort study analyzed the association between LUTS and depression in men over 40 years old from a rural Korean community. As the severity of LUTS increased, the risk of depression also significantly increased. Depression is one of the most common mental illnesses, and is increasing in prevalence. Given the correlation with suicide, this is a public health issue deserving of worldwide attention. A cross-sectional study of 229,595 adults in 2009 found that the prevalence of DEP and depression was 11.0% and 3.7%, respectively [18]. Urinary incontinence and overactive bladder are two urologic diseases that are relevant to depression. These two diseases are also closely related to age. These conditions also disturb sleep, which can affect quality of life for the patient and family members [19-21]. Our study also reveals that depression is not only related to LUTS severity, but also to age. Several studies have demonstrated that LUTS relevant to BPH is closely related to age, depression, and quality of life. The relationship between LUTS and depression was not apparent in all cases [22]. Regardless, this correlation is clear. Quality of life decreases with increasing LUTS severity. Eckhard et al. [23] reported that quality of life worsens with increasing severity of urinary frequency and residual urine volume. In addition, LUTS not only affects quality of life for the patient, but also for family members. Gannon et al. [24] commented that older individuals suffering from prostatic disease have negative thoughts, in general. Men often have a sense of shame and anxiety stemming from their urologic diseases [25]. In a Taiwanese population, 2% of patients diagnosed with BPH developed depression; this risk was 1.87 times higher than that of people without BPH [26]. Johnson et al. [27] reported that the prevalence of depression increases as the severity of LUTS increases. Similarly, in our study, there was a positive correlation between LUTS severity and depression prevalence. Nocturia causes insomnia, affects patients emotionally, and is directly related to depression [19,28]. One study found that frequent urination, weak stream, urgency, and nocturia all significantly affected depression [29]. Breyer et al. [30] performed a cross-sectional study in which 2,890 study participants were surveyed regarding the connection between depression and suicidal ideation depending on LUTS. Hesitancy, residual urine, and nocturia aggravated DEP. As the symptoms worsened, DEP similarly worsened. Nocturia has a close relationship with suicidal ideation. In this study, depression was associated with residual urine, weak stream, frequent urination, urgency, and nocturia. There were stronger relationships between depression and frequent urination, urgency, straining, weak stream, and nocturia. Storage and voiding symptoms were also related to depression. Voiding symptoms were more strongly correlated to depression than storage symptoms. Pietrzyk et al. [31] reported that, in BPH patients, there are several elements that influence depression, including a sense of loneliness, cardiovascular disease, and severe LUTS. Wong et al. [32,33] found that in a Chinese population, loneliness, smoking, cardiovascular disease, corticosteroid use, and severe LUTS influenced depression development in BPH patients. In addition, the group found that as LUTS worsened, its correlation with DEP increased. Several studies have recognized the relationship between BPH and depression, and the severity of LUTS is an important element influencing depression. This study is based on a local community population by a research institute so that consistent follow-up is possible. An additional study targeting the same cohort should be possible through ongoing follow-up. In addition, as an objective examination for BPH and depression is in progress, more information can be determined by comparing research and clinical findings based on objective indices. This study has several limitations. For instance, we were not able to assess causality or the predictors relating LUTS and depression. In addition, this study was based on a small sample of patients. Our results probably cannot be generalized to the entire Korean male population. Future prospective studies may clarify the relationship and causality between LUTS and depression. These data would emphasize the importance of the correlation, and the need for screening and LUTS treatment. In conclusion, men with severe LUTS have a higher risk of depression than do those with mild and moderate LUTS. The severity of voiding symptoms worsens the DEPs. Given its potential influence on depression and quality of life, there is a need for more aggressive urological diagnosis and treatment of LUTS.
  27 in total

1.  Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in Southern Chinese men: a prospective study.

Authors:  Samuel Y Wong; Jean Woo; Jason C Leung; Ping C Leung
Journal:  Aging Male       Date:  2010-06       Impact factor: 5.892

2.  Increased risk of depressive disorder following the diagnosis of benign prostatic enlargement: one-year follow-up study.

Authors:  Chao-Yuan Huang; Kuan-Ming Chiu; Shiu-Dong Chung; Joseph J Keller; Chung-Chien Huang; Herng-Ching Lin
Journal:  J Affect Disord       Date:  2011-08-06       Impact factor: 4.839

3.  Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.

Authors:  M D Eckhardt; G E van Venrooij; H H van Melick; T A Boon
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

4.  Major depression drives severity of American Urological Association Symptom Index.

Authors:  Timothy V Johnson; Ammara Abbasi; Samantha S Ehrlich; Renee S Kleris; Siri L Chirumamilla; Evan D Schoenberg; Ashli Owen-Smith; Charles L Raison; Viraj A Master
Journal:  Urology       Date:  2010-12       Impact factor: 2.649

5.  Men's experiences of having lower urinary tract symptoms: factors relating to bother.

Authors:  Lesley Glover; Kenneth Gannon; Joanne McLoughlin; Mark Emberton
Journal:  BJU Int       Date:  2004-09       Impact factor: 5.588

6.  The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey.

Authors:  Benjamin N Breyer; Stacey A Kenfield; Sarah D Blaschko; Bradley A Erickson
Journal:  J Urol       Date:  2013-12-14       Impact factor: 7.450

7.  Global burden of depressive disorders in the year 2000.

Authors:  T B Ustün; J L Ayuso-Mateos; S Chatterji; C Mathers; C J L Murray
Journal:  Br J Psychiatry       Date:  2004-05       Impact factor: 9.319

8.  Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

Authors:  J Kellogg Parsons
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-09-07

9.  Nocturia is the Lower Urinary Tract Symptom With Greatest Impact on Quality of Life of Men From a Community Setting.

Authors:  Eduardo de Paula Miranda; Cristiano Mendes Gomes; Fábio César Miranda Torricelli; José de Bessa; José Everton de Castro; Bruno Roberto da Silva Ferreira; Ariel Gustavo Scafuri; Homero Bruschini; Miguel Srougi
Journal:  Int Neurourol J       Date:  2014-06-26       Impact factor: 2.835

10.  Depressive symptoms in patients diagnosed with benign prostatic hyperplasia.

Authors:  Barbara Pietrzyk; Magdalena Olszanecka-Glinianowicz; Aleksander Owczarek; Tomasz Gabryelewicz; Agnieszka Almgren-Rachtan; Andrzej Prajsner; Jerzy Chudek
Journal:  Int Urol Nephrol       Date:  2015-02-12       Impact factor: 2.370

View more
  9 in total

1.  Qualitative insights into the experiences of living with moderate-to-severe lower urinary tract symptoms among community-dwelling ageing males.

Authors:  Lorna Kwai Ping Suen; Hui Lin Cheng; Simon Kai Wang Yeung; Cypher Ho Au-Yeung; Jillianne Chi Yen Lee; Kathy Kit Ying Ho; Natalie Ming Yan Lau; Cristina Ka Fu Ng; Iris Wai Sze Chan
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

2.  Depression is a major risk factor for the development of dementia in people with lower urinary tract symptoms: A nationwide population-based study.

Authors:  Ming-Jung Ou; Chun-Che Huang; Yi-Chi Wang; Yung-Liang Chen; Chung-Han Ho; Ming-Ping Wu; Yu-Tung Huang; Chien-Yi Wu; Ping-Jen Chen
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

3.  The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom.

Authors:  Haiqin Tang; Zhiqiang Zhang; Linlin Yang; Xin Chen; Zhiqi Liu; Wei Sun; Dexin Yu
Journal:  Int J Gen Med       Date:  2021-12-03

4.  Survey on disease insight and prevalence of urinary incontinence in women.

Authors:  Kang Hee Shim; Seol Ho Choo; Sung Gon Park; Hee Jae Yoo; Jong Bo Choi
Journal:  Investig Clin Urol       Date:  2021-09

5.  Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients.

Authors:  Kirill Kosilov; Irina Kuzina; Vladimir Kuznetsov; Olga Barabash; Ekaterina Fedorishcheva
Journal:  Asian J Urol       Date:  2021-04-20

6.  Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.

Authors:  Kyu-Sung Lee; Tag Keun Yoo; Limin Liao; Jianye Wang; Yao-Chi Chuang; Shih-Ping Liu; Romeo Chu; Budiwan Sumarsono
Journal:  BMC Urol       Date:  2017-11-21       Impact factor: 2.264

7.  Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey.

Authors:  Jung Ki Jo; Kyu Shik Kim; Ji Won Nam; Bo Yul Choi; Hong Sang Moon
Journal:  Int Neurourol J       Date:  2017-06-21       Impact factor: 2.835

8.  The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea.

Authors:  Tag Keun Yoo; Kyu-Sung Lee; Budiwan Sumarsono; Sung-Tae Kim; Hyun-Jung Kim; Hyun-Cheol Lee; Sun-Hwa Kim
Journal:  Investig Clin Urol       Date:  2018-04-23

9.  Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea.

Authors:  Jung Ki Jo; Sung Ho Shinn; Kyu Shik Kim; Hong Sang Moon
Journal:  Int Neurourol J       Date:  2021-01-27       Impact factor: 2.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.